Recent Reports



Evidence report on cystic fibrosis. Due to the COVID-19 pandemic, the public meeting to discuss this report has been postponed to August 27, 2020. 

View More on this Topic


Evidence report on sickle cell disease. This report will serve as the basis for discussion during a public meeting of the New England CEPAC on March 26, 2020.

View More on this Topic

Materials

ICER

Alternative Policies for Pricing Novel Vaccines and Drug Therapies for COVID-19

ICER

COVID-19: Updated Assessment

ICER

COVID-19: Preliminary Assessment

CTAF

Anemia in Chronic Kidney Disease: Open Input Period

ICER

2020 Unsupported Price Increase Report: Protocol

ICER

Methods adaptations for evaluating pricing during a pandemic

ICER

COVID-19: Public Comments on Preliminary Assessment

Midwest CEPAC

High Cholesterol Update: Stakeholder List

Midwest CEPAC

High Cholesterol Update: Draft Scoping Document

Midwest CEPAC

High Cholesterol Update: Open Input

ICER

Alternative Pricing Models for Remdesivir and Other Potential Treatments for COVID-19

New England CEPAC

Hemophilia A: Evidence Presentation